High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and is not a clinically homogeneous disease, but subsets of patients with distinct prognosis and response to therapy can be identified by genome-wide analyses. Mutations in major PDAC driver genes were associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Curia, Maria Cristina, Fantini, Fabiana, Lattanzio, Rossano, Tavano, Francesca, Di Mola, Francesco, Piantelli, Mauro, Battista, Pasquale, Di Sebastiano, Pierluigi, Cama, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518703/
https://www.ncbi.nlm.nih.gov/pubmed/31088413
http://dx.doi.org/10.1186/s12885-019-5616-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518703/
https://www.ncbi.nlm.nih.gov/pubmed/31088413
http://dx.doi.org/10.1186/s12885-019-5616-2

Ejemplares similares